Abstract
The aim of this study is to reveal the usefulness of semi-quantitative assessment using201 Tl chloride (Tl) single photon emission computed tomography (SPECT) (Tl SPECT) to evaluate the effectiveness of radiotherapy in 15 patients with oral cavity squamous cell carcinma (SCC). Fifteen patients were diagnosed with SCC by biopsy. All 15 patients enrolled in this study were planned to undergo preoperative radiotherapy with or without chemotherapy using carboplatin (CBDCA) and received reduction operation. Tl SPECTs were performed 15 minutes after intravenous administration of 111 MBq201T1 chloride. Regions of Interest (ROI) were set up around tumor (T), and non-lesion (N) at the part of contralateral scalp at the height of the cerebellum. The ratios of mean counts in ROI of the tumor to those in non-lesion were measured as pre- and post-treatment T/N ratios (pre T/N, post T/N). Furthermore, reduction rate (RR) was obtained by calculating [(pre T/N - post T/N)/(pre T/ N)] x 100%. Each parameter (pre T/N, post T/N, and RR) was compared to histopathological grade of surgical specimen based on the Oboshi and Shimosato classification (grade I-IV). RR showed significantly higher values in grade III and IV than in grade I and II (p = 0.0008). In conclusion, semi-quantitative assessment using Tl SPECT, especially calculating RR, is useful to evaluate the effectiveness of preoperative radiotherapy.
Similar content being viewed by others
REFERENCES
Kirita T, Ohgi K, Shimooka H, Yamanaka Y, Takebayashi S, Yamamoto K, et al. Preoperative concurrent chemo-radiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results.Oral Oncol 1999; 35: 597–606.
Valentino J, Spring PM, Shane M, Arnold SM, Regine WF. Interval pathologic assessments in patients treated with concurrent hyperfractionated radiation and intraarterial cisplatin (HYPERRADPLAT).Head Neck 2002; 24: 539–544.
Moustafa HM, Omar WM, Ezzat I, Ziada GA, el-Ghonomy EG.201T1 single photon emission tomography in the evaluation of residual and recurrent astrocytoma.Nucl Med Commun 1994; 15: 140–143.
Yoshii Y, Satou M, Yamamoto T, Yamada Y, Hyodo A, Nose T, et al. The role of thallium-201 single photon emission tomography in the investigation and characterization of brain tumours in man and their response to treatment.Eur J Nucl Med 1993; 20: 39–45.
Loberboym M, Mandell LR, Mosesson RE, Germano I, Lou W, DaCosta M, et al. The role of thallium-201 uptake and retention in intracranial tumors after radiotherapy.J Nucl Med 1997; 38: 223–226.
Loberboym M, Baram J, Feibel M, Hercbergs A, Lieberman L. A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden.Int J Radial Oncol Biol Phys 1995 ; 32: 249–254.
Yamaji S. Usefulness of201Tl SPECT in the evaluation of treatment effect for primary lung cancer.KAKU IGAKU (Jpn J Nucl Med) 1995; 32: 1333–1340. (in Japanese)
Shimizu M, Seto H, Kageyama M, Wu YW, Morijiri M, Watanabe N, et al. Assessment of treatment response in irradiated lung cancer by sequential thallium-201 SPECT: comparison with tumor volume change and survival time.Radiat Med 1996; 14: 7–12.
Suga K, Kume N, Nishigauchi K, Ogasawara N, Hara A, Miura G, et al.201Tl SPECT as an indicator for early prediction of therapeutic effects in patients with non-small cell lung cancer.Ann Nucl Med 1998; 12: 355–362.
Yoshimura N, Fukumoto M, Akagi N, Yoshida S. Diagnosis of lung cancer using functional image of201T1 SPECT with parameter of201Tl retention—evaluation of it applicability to post irradiated lung cancer.KAKU IGAKU (Jpn J Nucl Med) 1996; 33: 383–390. (in Japanese)
Kostakoglu L, Panicek DM, Divgi CR, Botet J, Healey J, Larson SM, et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas.Eur J Nucl Med 1995; 22: 1232–1237.
Nakahara T, Togawa T, Nagata M, Kikuchi K, Hatano K, Yui N, et al. Comparison of barium swallow, CT and thallium-201 SPECT in evaluating responses of patients with esophageal squamous cell carcinoma to preoperative chemotherapy.Ann Nucl Med 2003; 17: 583–591.
Togawa T, Yui N, Kinoshita F, Yanagisawa M, Hatano K, Sekiya Y, et al. Thallium-201 single-photon emission tomography in the treatment follow-up of nasopharyngeal carcinoma.Eur J Nucl Med 1997; 24: 305–311.
Kostakoglu L, Uysal U, Ozyar E, Elahi N, Hayra M, Uzal D, et al. Pre- and post-therapy thallium-201 and technetium-99m sestamibi SPECT in nasopharyngeal carcinoma.J Nucl Med 1996; 37: 1956–1962.
Kostakoglu L, Uysal U, Ozyar E, Hayra M, Uzal D, Demirkazik FB, et al. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.J Nucl Med 1997; 38: 1009–1014.
Omura K, Suzuki H, Takeuchi Y, Harada H, Hatano K, Togawa T. Prospective concurrent CBDCA chemotherapy and accelerated hyperfractionated radiotherapy for squamous cell carcinoma of the maxillary region.Head Neck Cancer 2001 ; 27: 663–669. (in Japanese)
Nagamachi S, Jinnouchi S, Flores LG 2nd, Nakahara H, Ono S, Ohnishi T, et al. The use of201Tl SPECT to predict the response to radiotherapy in patients with head and neck cancer.Nucl Med Commun 1996; 17: 935–942.
Spector JG, Sessions DG, Haughey BH, Cha KS, Simpson J, Mofty EI, et al. Delayed regional metastases distant metastases, and second primary malignancies in squamous cell carcinoma of the larynx and hypopharynx.Laryngoscope 2001; 111: 1079–1087.
Shimosato Y, Oboshi S, Baba K. Histopathological evaluation of effects of radiotherapy and chemotherapy for carcinomas.Jpn J Clin Oncol 1971; 1: 19–35.
Pericot J, Escriba JM, Valdes A, Biosca MJ, Monner A, Castellsague X, et al. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx.J Craniomaxillofac Surg 2000; 28: 49–55.
Mohr C, Bohndor W, Carstens J, Harle F, Hausamen JE, Hirche H, et al. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).In J Ora Maxillofac Surg 1994; 23: 140–148.
Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.Clin Cancer Res 2002; 8: 885–892.
Tartaglino LM, Rao VM, Markiewicz DA. Imaging of radiation change in the head and neck.Semin Roentgenol 1994; 29: 81–91.
Ng SH, Wan YL, Ko SF, Chang JT. MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy.J Magn Reson Imaging 1998; 8: 327–336.
Brau OM, Neumeister B, Neuhold N, Siebenhandl A, Wimmer M, Holzner JH, et al. Histological grading of therapy induced regression in squamous cell carcinomas of the oral cavity. A morphological and immunohistochemical study.Pathol Res Pract 1989; 185: 368–372.
Ando A, Ando I, Katayama M, Sanada S, Hiraki T, Tonami N, et al. Biodistributions of201Tl in tumor bearing animals and inflammatory lesion induced animals.Eur J Nucl Med 1987; 12: 567–572.
Ando A, Ando I, Sanada S, Hiraki T, Takeuchi T, Hisada K, et al. Relationship between the biodistributions of radioactive metal nuclide in tumor tissue and the physicochemical properties of these metal ions.Ann Nucl Med 1999; 13: 83–88.
Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas.J Neurosurg 1989; 71: 342–346.
Jinnouchi S, Hoshi H, Ohnishi T, Futami S, Nagamachi S, Watanabe K, et al. Thallium-201 SPECT for predicting histological type of meningiomas.J Nucl Med 1993; 34: 2091–2094.
Tonami N, Shuke N, Yokoyama K, Seki H, Takayama T, Kinuya S, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer.J Nucl Med 1989; 30: 997–1004.
Takekawa H, Itoh K, Abe S, Ogura S, Isobe H, Furudate M, et al. Thallium-201 uptake, histopathological differentiation and Na-K ATPase in lung adenocarcinoma.J Nucl Med 1996; 37: 955–958.
Nagamachi S, Hoshi H, Jinnouchi S, Ohnishi T, Flore LG 2nd, Futami S, et al.201Tl SPECT for evaluating head and neck cancer.Ann Nucl Med 1996; 10: 105–111.
Israel O, Gorenberg M, Frenkel A, Kuten A, Jerushalmi J, Kolodny GM, et al. Local and systemic effect of radiation on bone metabolism measured by quantitative SPECT.J Nucl Med 1992; 33: 1774–1780.
Staudenherz A, Selzer E, Kochl H, Leitha T. Effects of irradiation of99mTc sestamibi and201T1 uptake in a human papillary thyroid carcinoma cell line.Nucl Med Commun 2002; 23: 565–568.
Kitagawa Y, Sadato N, Azuma H, Ogasawara T, Yoshida M, Ishii Y, et al. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.J Nucl Med 1999; 40: 1132–1137.
Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.Head Neck 2002; 24: 127–135.
Rege S, Maass A, Chaiken L, Hoh CK, Choi Y, Lufkin R, et al. Use of positron emission tomography with fluoro-deoxyglucose in patients with extracranial head and neck cancers.Cancer 1994; 73: 3047–3058.
Greven KM, Williams DW 3rd, Keyes JW Jr, McGuirt WF, Watson NE Jr, Randall ME, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.Cancer 1994; 74: 1355–1359.
Sakamoto H, Nakai Y, Ohashi Y, Matsuda M, Sakashita T, Nasako Y, et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.Acta Otolaryngol Suppl 1998; 538: 254–260.
Lindholm P, Leskinen-Kallio S, Grenman R, Lehikoinen P, Nagren K, Teras M, et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine.Int J Radiat Oncol Biol Phys 1995; 32: 787–794.
De Vicente JC, Recio OR, Pendas SL, Lopez-Arranz JS. Oral squamous cell carcinoma of the mandibular region: A survival study.Head Neck 2001; 23: 536–543.
Cano E, Flickinger J, Johnson J. Multi variate analysis result of radiotherapy for laryngeal cancer.Head Neck 1993; 15: 382–388.
Nathu RM, Mancuso A A, Zhu TC, Mendenhall WM. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy.Head Neck 2000; 22: 1–5.
Overgaard J, Hansen HS, Jorgensen K, Hjelm Hansen M. Primary radiotherapy of larynx and pharynx carcinoma— an analysis of some factors influencing local control and survival.Int J Radiat Oncol Biol Phys 1986; 12: 515–521.
Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, et al. Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.Int J Radiat Oncol Biol Phys 1994; 30: 1201–1206.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suzuki, A., Togawa, T., Kuyama, J. et al. Semi-quantitative assessment of oral cavity squamous cell carcinoma using201 TI SPECT for evaluating effectiveness of preoperative radiotherapy. Ann Nucl Med 18, 433–441 (2004). https://doi.org/10.1007/BF02984487
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02984487